164 related articles for article (PubMed ID: 8973939)
21. [Renal cell carcinoma with colon metastases: an infrequent site for metastases].
Valdespino-Castillo VE; Ruiz-Jaime A
Cir Cir; 2008; 76(4):339-42. PubMed ID: 18778546
[TBL] [Abstract][Full Text] [Related]
22. Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level.
Akaza H; Tsukamoto T; Fujioka T; Tomita Y; Kitamura T; Ozono S; Miki T; Naito S; Zembutsu H; Nakamura Y
Jpn J Clin Oncol; 2011 Aug; 41(8):1023-30. PubMed ID: 21642665
[TBL] [Abstract][Full Text] [Related]
23. Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low-dose interferon therapy.
Nemoto K; Miura T; Shioji G; Tsuboi N
Hemodial Int; 2011 Apr; 15(2):288-92. PubMed ID: 21395974
[TBL] [Abstract][Full Text] [Related]
24. [Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].
Schenck M; Börgermann C; Jäger T; vom Dorp F; Sperling H; Rübben H; Lümmen G
Urologe A; 2007 May; 46(5):528-34. PubMed ID: 17356836
[TBL] [Abstract][Full Text] [Related]
25. A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
Miwa S; Mizokami A; Konaka H; Izumi K; Nohara T; Namiki M
Jpn J Clin Oncol; 2009 Nov; 39(11):745-50. PubMed ID: 19808839
[TBL] [Abstract][Full Text] [Related]
26. Regression of pulmonary and multiple skeletal metastases from renal cell carcinoma by nephrectomy and alpha-interferon therapy: a case report.
Ibayashi K; Ando M; Gotoh E
Jpn J Clin Oncol; 1993 Dec; 23(6):378-83. PubMed ID: 8283792
[TBL] [Abstract][Full Text] [Related]
27. [A case of renal cell carcinoma effectively treated by interferon-alpha and embolization of the renal artery].
Tsujimura A; Imazu T; Nishimura K; Sugao H; Oka T; Takaha M; Takeda M; Kurata A
Hinyokika Kiyo; 1993 Nov; 39(11):1039-42. PubMed ID: 8266872
[TBL] [Abstract][Full Text] [Related]
28. Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.
Boikos SA; Hammers HJ
J Clin Oncol; 2012 Oct; 30(29):e299. PubMed ID: 22949145
[No Abstract] [Full Text] [Related]
29. Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.
Aksoy H; Baltaci S; Türkölmez K; Seçkiner I; Bedük Y
Int Urol Nephrol; 2001; 33(3):457-9. PubMed ID: 12230271
[TBL] [Abstract][Full Text] [Related]
30. [A case of complete resolution of multiple metastases of advanced renal cell carcinoma following partial jejunotomy in intestinal metastases and interferon therapy].
Miyata M; Watabe Y; Okamura K; Fujisawa M; Arima S; Yachiku S
Hinyokika Kiyo; 1988 Oct; 34(10):1783-8. PubMed ID: 3245527
[TBL] [Abstract][Full Text] [Related]
31. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
[No Abstract] [Full Text] [Related]
32. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report].
Wang C; Takeda K; Shiba M; Takayama H; Munakata S
Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106
[TBL] [Abstract][Full Text] [Related]
33. Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY).
Bracarda S; Porta C; Boni C; Santoro A; Mucciarini C; Pazzola A; Cortesi E; Gasparro D; Labianca R; Di Costanzo F; Falcone A; Cinquini M; Caserta C; Paglino C; De Angelis V
Eur Urol; 2013 Feb; 63(2):254-61. PubMed ID: 22964169
[TBL] [Abstract][Full Text] [Related]
34. [Bilateral adrenal masses from renal cell carcinoma: a case report].
Shioi K; Muraoka K; Tomoda T; Yoshida M; Takase K; Kishi H; Noguchi S
Hinyokika Kiyo; 2006 Jan; 52(1):19-21. PubMed ID: 16479984
[TBL] [Abstract][Full Text] [Related]
35. [Advanced renal cell carcinoma showing a different response to two types of interferon-alpha].
Horiguchi A; Uchida A
Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):50-3. PubMed ID: 14978941
[TBL] [Abstract][Full Text] [Related]
36. Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis.
Akaza H; Kawai K; Tsukamoto T; Fujioka T; Tomita Y; Kitamura T; Ozono S; Miki T; Naito S; Zembutsu H; Nakamura Y
Jpn J Clin Oncol; 2010 Jul; 40(7):684-9. PubMed ID: 20382632
[TBL] [Abstract][Full Text] [Related]
37. [Two cases of malignancy-associated hypercalcemia from bone metastases of breast cancer successfully treated with combination therapy using pamidronate and calcitonin].
Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
Gan To Kagaku Ryoho; 2000 May; 27(5):763-6. PubMed ID: 10832449
[TBL] [Abstract][Full Text] [Related]
38. Disappearance of metastatic renal cell carcinoma to the base of the tongue after systemic administration of interferon-alpha.
Shibayama T; Hasegawa S; Nakamura S; Tachibana M; Jitsukawa S; Shiotani A; Morinaga S
Eur Urol; 1993; 24(2):297-9. PubMed ID: 8375454
[TBL] [Abstract][Full Text] [Related]
39. [Management of advanced renal cell carcinoma: surgical treatment of metastasis].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1994 Oct; 40(10):919-24. PubMed ID: 7992709
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia upon recurrence of renal cell carcinoma producing parathyroid hormone-related protein.
Ueno M; Tokonabe S; Kuroda I; Tsukamoto T; Deguchi N
Scand J Urol Nephrol; 2003; 37(3):265-8. PubMed ID: 12775288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
